Canada markets closed

Edwards Lifesciences Corporation (4EW.TI)

TLO - TLO Delayed Price. Currency in EUR
Add to watchlist
85.90+2.00 (+2.38%)
At close: 04:37PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.11
52-Week Change 33.91%
S&P500 52-Week Change 322.55%
52 Week High 388.14
52 Week Low 357.94
50-Day Moving Average 381.53
200-Day Moving Average 374.21

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 8596.59M
% Held by Insiders 10.89%
% Held by Institutions 184.74%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 23:1
Last Split Date 3Jun 01, 2020

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 23.01%
Operating Margin (ttm)27.39%

Management Effectiveness

Return on Assets (ttm)12.05%
Return on Equity (ttm)21.28%

Income Statement

Revenue (ttm)6.14B
Revenue Per Share (ttm)10.15
Quarterly Revenue Growth (yoy)9.50%
Gross Profit (ttm)N/A
EBITDA 1.92B
Net Income Avi to Common (ttm)1.41B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)3.30%

Balance Sheet

Total Cash (mrq)1.7B
Total Cash Per Share (mrq)2.82
Total Debt (mrq)699.2M
Total Debt/Equity (mrq)9.73%
Current Ratio (mrq)3.76
Book Value Per Share (mrq)11.82

Cash Flow Statement

Operating Cash Flow (ttm)528.2M
Levered Free Cash Flow (ttm)671.94M